Related Experiment Video
Updated: May 4, 2026
Techniques for the Analysis of Extracellular Vesicles Using Flow Cytometry
Published on: March 17, 2015
Analysis of tissue factor positive microparticles
1Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, NC 27599, USA. Nigel_key@med.unc.edu
Abstract:
There has recently been intense interest in the clinical measurement of tissue factor (TF)-positive microparticles (MPs) in clinical disease states. This interest has been driven by the demonstration of an putative role for circulating TF-positive MPs in animal models of thrombus propagation. Both immunological and functional assays for MP-TF have been described. While each approach has its own advantages and drawbacks, neither has yet been truly established as the 'gold standard'. Heterogeneity of TF-bearing MPs, such as the variable co-expression of surface phosphatidylserine, may determine not only their procoagulant potential, but also additional properties including rate of clearance from the circulation.
Insights
Clinical measurement of tissue factor (TF)-positive microparticles (MPs) is gaining interest due to their role in thrombus propagation. Current assays for MP-TF have limitations, and MP heterogeneity influences their function and clearance.
Area of Science:
- Biomedical research
- Hematology
- Clinical diagnostics
Background:
- Tissue factor (TF)-positive microparticles (MPs) are implicated in thrombus propagation.
- Clinical measurement of circulating TF-positive MPs is of significant interest.
- TF-positive MPs may play a role in various disease states.
Purpose of the Study:
- To review the current state of clinical measurement of TF-positive MPs.
- To discuss the immunological and functional assays available for MP-TF.
- To highlight the challenges and potential of MP-TF measurement.
Main Methods:
- Review of existing immunological and functional assays for MP-TF.
- Discussion of MP heterogeneity and its impact.
- Analysis of the clinical relevance of TF-positive MPs.
Main Results:
- Both immunological and functional assays for MP-TF exist, but neither is a definitive gold standard.
- Heterogeneity of TF-bearing MPs, including phosphatidylserine co-expression, affects their procoagulant potential and clearance.
- Further research is needed to establish reliable and standardized methods for MP-TF measurement.
Conclusions:
- Standardized and validated assays are needed for reliable clinical measurement of TF-positive MPs.
- Understanding MP heterogeneity is crucial for interpreting their clinical significance.
- TF-positive MPs represent a promising area for clinical diagnostics and therapeutic targeting.
